News | Lung Imaging | March 09, 2021

The new thresholds can save lives and aid health equity efforts

Final U.S. Preventive Services Task Force (USPSTF) recommendations to lower the initial age and smoking history requirements for lung cancer screening (LCS) reconfirm the lifesaving ability of these tests and present an opportunity for providers to re-engage screening age patients to save more lives.

Getty Images


March 9, 2021 — Final U.S. Preventive Services Task Force (USPSTFrecommendations to lower the initial age and smoking history requirements for lung cancer screening (LCS) reconfirm the lifesaving ability of these tests and present an opportunity for providers to re-engage screening age patients to save more lives.

The American College of Radiology (ACR) urges the Center for Medicare and Medicaid Services (CMS) to quickly update its LCS National Coverage Decision to reflect the USPSTF changes. This combined USPSTF and CMS action would enable the medical community to strike a blow against the nation’s leading cancer killer by using LCS screening to its full advantage.

Screening eligibility expansion should spur more providers to start conversations with eligible patients that can ease lung cancer outcomes disparities — particularly among women, Black men and those in rural areas

Annual lung cancer screening with low-dose computed tomography (LDCT) in high-risk patients significantly reduces lung cancer deaths. Sadly, less than 15% of Americans who met previous USPSTF lung cancer screening criteria are tested each year. Given that the American Cancer Society predicts 131,880 lung cancer deaths in 2021, more-widespread screening could save 30,000–60,000 lives in the United States each year.

“Lung cancer kills more people each year than breast, colon and prostate cancers combined. Particularly with the expanded screening thresholds implemented nationwide, this cost-effective test can save more lives than any cancer-screening test in history. I urge primary care providers and pulmonologists to use this new information to start screening conversations with their recommended patients today,” said Debra Dyer, M.D., FACR, Chair of the ACR Lung Cancer Screening Steering Committee.

The underuse of LCS may, in part, be due to a large overestimation of LCS false-positive rates, which inflates assumptions of potential harms. The false-positive rate in clinical LCS practices using Lung-RADS structured reporting is 7–8% — similar to screening mammography. It is critical that physicians are up-to-date on current information so they can engage with their patients to make informed screening decisions.

“The Affordable Care Act mandates that private insurers incorporate updated USPSTF guidelines into coverage within one year. The healthcare community and advocates must contact insurers to  get these changes implemented as soon as possible so that primary care providers and thoracic specialists can act on the lower starting age and more-inclusive pack-year threshold to order these scans for their high-risk patients,” said Ella Kazerooni M.D., MS, FACR, Chair of the ACR Lung-RADS committee and Lung Cancer Screening Registry.

For more CT lung cancer screening information: RadiologyInfo.orgNLCRT.org and ACR Lung Cancer Screening Resources.

 


Related Content

News | Radiology Business

Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Sponsored Content | Videos | Radiology Business

Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...

Time November 11, 2025
arrow
News | Interventional Radiology

Nov. 10, 2025 — Interventional radiologists (IRs) that almost exclusively practice in their specialty provide more ...

Time November 11, 2025
arrow
News | Orthopedic Imaging

Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...

Time November 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Nov. 10, 2025 — There has been substantial progress in the past few years in the field of MRI in general and remote MR ...

Time November 11, 2025
arrow
News | Contrast Media

Nov. 10, 2025 — Scientists at the University of Birmingham have developed a new class of MRI contrast agents – improving ...

Time November 10, 2025
arrow
News | X-Ray

Oct. 30, 2025 – In collaboration with OBIO, University Health Network (UHN), Canada’s leading hospital and the No. 1 ...

Time November 03, 2025
arrow
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...

Time October 31, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
Subscribe Now